Clinical Trial Update: Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating apalutamide with a gonadotropin-releasing hormone analogue, with or without abiraterone acetate, in men with various stages of prosta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Stage Iib Prostate Cancer
• Stage Iic Prostate Cancer
• Stage Iiia Prostate Cancer
• Stage Iiic Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Apalutamide (apalutamide)
• Gonadotropin-releasing hormone analogue (gonadotropin-releasing hormone analogue)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8 | Phase 2 | Status: COMPLETED | Results posted: 2022-08-10